Drugs / CTX
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04296175 Comparator | Mar 2020 → Mar 2025 overdue | triple-negative breast carcinoma | Fudan University | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04296175 ↗ |